Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

Marianne Paesmans, Jean‐Paul Sculier, P Libert, +7

Journal of Clinical Oncology

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

Jean Klášterský, Jean‐Paul Sculier, H. Lacroix, +7

Journal of Clinical Oncology

Advanced NsclcMedicineCancer ManagementMetronomic TherapyPharmacology +12

Prognostic factors for patients with small cell lung carcinoma

Marianne Paesmans, Jean‐Paul Sculier, J. Lecomte, +9

Cancer

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

Jean Klášterský, Jean‐Paul Sculier, G. Bureau, +7

Journal of Clinical Oncology

Study ArmsMedicineCancer ManagementObjective Response RatePathology +10

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party

Marianne Paesmans, Jean‐Paul Sculier, P Libert, +8

European Journal of Cancer

MedicineCancer ManagementPathologyEuropean Lung CancerPredictive Value +6

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.

Jean‐Paul Sculier, Marianne Paesmans, G. Bureau, +7

Journal of Clinical Oncology

Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.

Jean‐Paul Sculier, M Paesmans, G. Bureau, +9

Journal of Clinical Oncology

Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer

J.J. Body, J.P. Sculier, N. Raymakers, +13

Cancer

Scc AgAdvanced Lung DiseaseScc Ag LevelScc Ag LevelsMedicine +12

Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.

Jean‐Paul Sculier, Jean Klášterský, V. Giner, +7

Journal of Clinical Oncology

A Phase IiPharmacotherapyModerate-dose CisplatinOncologyCisplatin Arm +14

A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy

Jean‐Paul Sculier, Marianne Paesmans, J.J. Lafitte, +12

Annals of Oncology